Clinical Trials · NCT04276597
Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Excel Diagnostics and Nuclear Oncology Center
- Enrollment
- 0
- Start date
- Mar 2020
- Locations
- 1 site, United States
- Primary endpoint
- Assessment of the overall response rate